- Report
- January 2024
- 200 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- April 2024
- 189 Pages
Global
From €4778EUR$4,950USD£4,098GBP
- Clinical Trials
- February 2024
- 80 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Report
- July 2023
- 76 Pages
Global
From €3373EUR$3,495USD£2,894GBP
- Report
- January 2024
- 200 Pages
Global
From €4006EUR$4,150USD£3,436GBP
- Report
- November 2022
- 100 Pages
Global
From €5743EUR$5,950USD£4,926GBP
- Report
- August 2022
- 30 Pages
Global
From €3137EUR$3,250USD£2,691GBP
- Report
- January 2022
- 200 Pages
Global
From €7239EUR$7,500USD£6,210GBP
- Report
- January 2022
- 60 Pages
Global
From €3813EUR$3,950USD£3,270GBP
- Report
- May 2021
- 112 Pages
Global
From €4343EUR$4,500USD£3,726GBP
- Report
- January 2020
- 100 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- August 2022
Global
From €763EUR$790USD£654GBP
- Report
- February 2021
Global
From €2857EUR$2,960USD£2,451GBP
- Report
- June 2019
- 26 Pages
Global
From €3856EUR$3,995USD£3,308GBP
- Drug Pipelines
- March 2021
Global
From €2413EUR$2,500USD£2,070GBP
- Drug Pipelines
- July 2020
- 195 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Report
- February 2024
- 90 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Report
- August 2021
- 77 Pages
Global
From €3200EUR$3,552USD£2,841GBP
The Post Traumatic Stress Disorder (PTSD) Drug market is a subset of the Mental Disorders Drugs market. PTSD is a mental health condition that can develop after a person experiences a traumatic event. It is characterized by symptoms such as flashbacks, nightmares, and difficulty sleeping. Treatment for PTSD typically includes psychotherapy and medications. Common medications used to treat PTSD include selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and atypical antipsychotics.
The PTSD Drug market is expected to grow due to increasing prevalence of PTSD, rising awareness about mental health, and increasing government initiatives to reduce the stigma associated with mental health disorders. Additionally, the development of novel drugs and the increasing use of digital therapeutics are expected to drive the market growth.
Some companies in the PTSD Drug market include Eli Lilly, Pfizer, GlaxoSmithKline, Johnson & Johnson, Merck, and Novartis. Show Less Read more